The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments-Reference-Cited by-同舟云学术

The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments

Published:2007-10-01 Issue:10 Volume:12 Page:1183-1193
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Gridelli Cesare¹,Maione Paolo¹,Rossi Antonio¹,De Marinis Filippo²

Affiliation:

1. a Division of Medical Oncology, “S.G. Moscati” Hospital, Avellino, Italy

2. b I Division of Oncological Pneumology, Department of Lung Diseases, San Camillo-Forlanini Hospitals, Roma, Italy

Abstract

Learning Objectives After completing this course, the reader will be able to: Describe the main clinical trials of bevacizumab combined with chemotherapy in the treatment of advanced NSCLC.Describe the main clinical trials of bevacizumab combined with other targeted therapies in the treatment of advanced NSCLC.Describe some ongoing trials of bevacizumab in the treatment of NSCLC and try to define future developments of bevacizumab in this clinical setting. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-10-1183

Reference51 articles.

1. Cancer Statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

3. Adjuvant chemotherapy for non-small cell lung cancer;Bria;J Thorac Oncol,2007

4. Current treatment paradigms for locally advanced non-small cell lung cancer;Rigas;J Thorac Oncol,2007

5. Optimizing chemotherapy for patients with advanced non-small cell lung cancer;Scagliotti;J Thorac Oncol,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study;Respiratory Investigation;2023-09

2. Effectiveness and Safety of Adding Bevacizumab to Platinum-Based Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis;Frontiers in Medicine;2021-06-30

3. Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment;Biomaterials Science;2020

4. Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma;Cancers;2020-01-01

5. Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen;Journal of Cancer;2020